CAT No: C07006
CAS No: 133407-82-6
Synonyms/Alias: MG-132;133407-82-6;Z-Leu-leu-leu-al;MG132;MG 132;Zlllal;Z-Leu-leu-leucinal;Z-LLL-CHO;Zlll-cho;Z-Leu-Leu-Leu-H;Carbobenzoxy-leucyl-leucyl-leucinal;C26H41N3O5;Benzyloxycarbonylleucyl-leucyl-leucine aldehyde;Benzyloxycarbonyl-leu-leu-leu-aldehyde;Benzyloxycarbonyl-leucyl-leucyl-leucinal;Benzyl ((S)-4-methyl-1-(((S)-4-methyl-1-(((S)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)carbamate;Carbobenzoxyl-leucinyl-leucinyl-leucinal-H;Cbz-Leu-Leu-Leu-H;MFCD00674886;benzyl (S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate;RF1P63GW3K;CHEMBL64925;N-[(Phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-L-leucinamide;Cbz-L-Leu-L-Leu-L-Leu-CHO;DTXSID3042639;CHEBI:75142;Lll cpd;(S)-N-((Phenylmethoxy)carbonyl)-L-leucyl-N-(1-formyl-3-methylbutyl)-L-leucinamide;N-[(Benzyloxy)carbonyl]-L-Leucyl-N-[(2s)-4-Methyl-1-Oxopentan-2-Yl]-L-Leucinamide;BRD0970;BRD-0970;Z-LLL;(S)-MG132;phenylmethyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate;n-benzyloxycarbonyl-l-leucyl-l-leucyl-l-leucinal;1211877-36-9;UNII-RF1P63GW3K;Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal;N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-L-leucinamide;zLLL;Benzyl N-[(1S)-3-methyl-1-[[(1S)-3-methyl-1-[[(2S)-4-methyl-1-oxo-pentan-2-yl]carbamoyl]butyl]carbamoyl]butyl]carbamate;phenylmethyl N-((2S)-4-methyl-1-(((2S)-4-methyl-1-(((2S)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)carbamate;Z-LLLal;Cbz-Leu-Leu-Leucinal;Z-LLL-H;Z-L-leu-L-leu-L-leu-H;BSPBio_001310;carbobenzoxy-Leu-Leu-leucinal;KBioGR_000030;KBioSS_000030;MLS006011220;Cbz-L-Leu-L-Leu-L-Leu-H;SCHEMBL160925;GTPL8616;DTXCID1022639;BCBcMAP01_000028;KBio2_000030;KBio2_002598;KBio2_005166;KBio3_000059;KBio3_000060;benzyloxycarbonyl-Leu-Leu-leucinal;Bio2_000030;Bio2_000510;GLXC-03835;HMS1361B12;HMS1791B12;HMS1989B12;HMS3402B12;EX-A1500;BDBM50069985;HB4135;NSC782153;PI-102;s2619;AKOS027420457;MG-132 [Z-Leu- Leu-Leu-CHO];CCG-207860;CCG-208036;CS-0471;FM29307;MG-132?;NSC-782153;compound 5b [PMID: 16686537];IDI1_033780;s10322;NCGC00161679-01;NCGC00161679-02;NCGC00161679-03;NCGC00161679-04;NCGC00161679-13;Z-Leu-Leu-Leu-al, >=90% (HPLC);AS-55854;benzyl N-[(1S)-3-methyl-1-{[(1S)-3-methyl-1-{[(2S)-4-methyl-1-oxopentan-2-yl]carbamoyl}butyl]carbamoyl}butyl]carbamate;HY-13259;SMR002530629;SW219780-1;UNM000011053701;Q3272916;SR-01000864598-1;BRD-K60230970-001-04-3;BRD-K60230970-001-05-0;BRD-K60230970-001-06-8;BRD-K60230970-001-07-6;BRD-K60230970-001-08-4;BRD-K60230970-001-10-0;BRD-K60230970-001-13-4;BRD-K60230970-001-16-7;BRD-K60230970-001-17-5;MG-132 - CAS 133407-82-6;MG-132, >/=95% by HPLC - CAS 133407-82-6;L-Leucinamide, N-((phenylmethoxy)carbonyl)-L-leucyl-N-((1S)-1-formyl-3-methylbutyl)-;L-Leucinamide, N-((phenylmethoxy)carbonyl)-L-leucyl-N-(1-formyl-3-methylbutyl)-, (S)-;L-Leucinamide, N-[(phenylmethoxy)carbonyl]-L-leucyl-N1-[(1S)-1-formyl-3-methylbutyl]-;(S)-4-methyl-2-(3-phenyl-propionylamino)-pentanoic acid [(S)-1-((S)-1-formyl-3-methyl-butylcarbamoyl)-3-methyl-butyl]-amide;{(S)-1-[(S)-1-((S)-1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester;{1-[(S)-(S)-1-((S)-1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester;{1-[1-(1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester;849-040-8;benzyl N-[(1S)-1-[[(1S)-1-[[(1S)-1-formyl-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate;benzyl(S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C26H41N3O5 |
M.W/Mr. | 475.6 |
Sequence | One Letter Code:LLL Three Letter Code:Cbz-Leu-Leu-Leu-al |
InChI | InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1 |
InChI Key | TZYWCYJVHRLUCT-VABKMULXSA-N |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.